{"transactions":[{"id":2239151,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Adm. Officer"}}],"security":"Common Stock","published_at":"2022-06-08T16:09:19.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":10800,"price":2.8632,"value":30922.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.78 to $3.12, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":122500,"source":{"system":"sec-edgar","filing":"0001209191-22-035014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000120919122035014/doc4.xml","form_type":"4"}},{"id":2239150,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Adm. Officer"}}],"security":"Common Stock","published_at":"2022-06-08T16:09:19.000Z","date":"2022-06-06","kind":"tax_withholding","acquired":false,"shares":6700,"price":2.8632,"value":19183.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represent shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 17,500 shares of Restricted Stock Units granted on March 3, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.78 to $3.12, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":133300,"source":{"system":"sec-edgar","filing":"0001209191-22-035014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000120919122035014/doc4.xml","form_type":"4"}},{"id":2350373,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Adm. Officer"}}],"security":"Common Stock","published_at":"2022-03-04T17:57:22.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (the \"RSU Award\") payable solely in common stock of the Issuer.  The shares subject to the RSU Award shall vest in equal quarterly installments over two years, with 1/8th of the total number of shares subject to the RSU Award vesting on each quarterly anniversary of the date of grant."}],"balance_after":140000,"source":{"system":"sec-edgar","filing":"0001209191-22-016441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000120919122016441/doc4.xml","form_type":"4"}},{"id":2444001,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Adm. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T17:08:44.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the date of grant, such that the total number of shares shall be fully vested on the four-year anniversary of the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":13.39,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-001792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000120919122001792/doc4.xml","form_type":"4"}},{"id":2944520,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Adm. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-15T18:59:09.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the shares will vest on March 31, 2023 provided that the Issuer's Compensation Committee has determined that Performance Condition No. 1 (as defined below) has been met, and 50% of the shares will vest on March 31, 2024 provided that the Issuer's Compensation Committee has determined that Performance Condition No. 2 (as defined below) has been met; provided further that, in each case, the grantee will have been continuously a service provider from the date of grant through each such vesting date. Performance Condition No. 1 means that the average closing price per share of the Issuer's common stock in any 45 consecutive trading day period prior to March 15, 2023 has exceeded $135 per share. Performance Condition No. 2 means that the average closing price per share of the Issuer's common stock in any 45 consecutive trading day period prior to March 15, 2024 has exceeded $170 per share."}],"balance_after":100000,"derivative":{"exercise_price":29.6,"expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-063600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000120919120063600/doc4.xml","form_type":"4"}},{"id":2944519,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Adm. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-15T18:59:09.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 48 equal monthly installments from the vesting commencement date, subject to the grantee's continuous service to the Issuer on each such date."}],"balance_after":75000,"derivative":{"exercise_price":29.6,"expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-20-063600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000120919120063600/doc4.xml","form_type":"4"}},{"id":3147313,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Adm. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-15T17:37:36.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the stock option shall vest on May 5, 2021 with the remaining vesting monthly over the next 36 months."}],"balance_after":200000,"derivative":{"exercise_price":45.88,"expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-20-029819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000120919120029819/doc4.xml","form_type":"4"}},{"id":3263505,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-02-19T20:23:23.000Z","date":"2020-02-15","kind":"tax_withholding","acquired":false,"shares":864,"price":25.33,"value":21885.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by and surrendered to the Issuer on February 15, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock Award (\"RSA\") for 2,500 shares.  The RSA vests in three equal annual installments from February 15, 2019, subject to Mrs. McDowell's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the \"Plan\")) on each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The fair market value was determined on February 14, 2020 pursuant to the Plan."}],"balance_after":23453,"source":{"system":"sec-edgar","filing":"0001479290-20-000033","document":"wf-form4_158216178578533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000147929020000033/wf-form4_158216178578533.xml","form_type":"4"}},{"id":3323311,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-01-03T18:46:59.000Z","date":"2019-12-31","kind":"other","acquired":true,"shares":382,"price":10.82,"value":4133.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired by Mrs. McDowell under the Issuer's 2014 Employee Stock Purchase Plan (the \"Plan\") on December 31, 2019 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).  Mrs. McDowell purchased the maximum number of shares allowable under the Issuer's Plan and Internal Revenue Code Section 423(b)(8) for the period ended December 31, 2019."}],"balance_after":24317,"source":{"system":"sec-edgar","filing":"0001479290-20-000004","document":"wf-form4_157809519931589.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000147929020000004/wf-form4_157809519931589.xml","form_type":"4"}},{"id":3471362,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Common Stock","published_at":"2019-07-02T21:14:19.000Z","date":"2019-06-28","kind":"other","acquired":true,"shares":1000,"price":11.0245,"value":11024.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired by Ms. McDowell under the Issuer's 2014 Employee Stock Purchase Plan (the \"Plan\") on June 28, 2019 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).  Ms. McDowell purchased the maximum number of shares allowable under the Issuer's Plan for the period ended June 30, 2019."}],"balance_after":23935,"source":{"system":"sec-edgar","filing":"0001479290-19-000075","document":"wf-form4_156211644435237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000147929019000075/wf-form4_156211644435237.xml","form_type":"4"}},{"id":3487820,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Common Stock","published_at":"2019-06-17T20:30:15.000Z","date":"2019-06-15","kind":"tax_withholding","acquired":false,"shares":1383,"price":10.86,"value":15019.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by and surrendered to the Issuer on June 15, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock award (\"RSA\") for 16,000 shares.  The RSA vests in four equal annual installments from June 15, 2018, subject to Ms. McDowell's Continuous Service (as defined in the Issuer's 2014 Inducement Plan (the Plan)) on each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The fair market value was determined on June 14, 2019, pursuant to the Plan."}],"balance_after":22935,"source":{"system":"sec-edgar","filing":"0001479290-19-000071","document":"wf-form4_156081780076449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000147929019000071/wf-form4_156081780076449.xml","form_type":"4"}},{"id":3686820,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-25T20:54:10.000Z","date":"2019-01-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from January 24, 2019, subject to Ms. McDowell's Continuous Service (as defined in the Plan) on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":17.23,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001479290-19-000016","document":"wf-form4_154846763329049.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000147929019000016/wf-form4_154846763329049.xml","form_type":"4"}},{"id":3686819,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Common Stock","published_at":"2019-01-25T20:54:10.000Z","date":"2019-01-24","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from February 15, 2019, subject to Ms. McDowell's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the \"Plan\")) on each vesting date."}],"balance_after":24318,"source":{"system":"sec-edgar","filing":"0001479290-19-000016","document":"wf-form4_154846763329049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000147929019000016/wf-form4_154846763329049.xml","form_type":"4"}},{"id":3713415,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Common Stock","published_at":"2019-01-02T20:05:59.000Z","date":"2018-12-31","kind":"other","acquired":true,"shares":818,"price":17.1105,"value":13996.389,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired by Ms. McDowell under the Issuer's 2014 Employee Stock Purchase Plan on December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":16818,"source":{"system":"sec-edgar","filing":"0001479290-19-000004","document":"wf-form4_154647754152580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000147929019000004/wf-form4_154647754152580.xml","form_type":"4"}},{"id":3947631,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-03T20:23:37.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest over a period of four years commencing on May 1, 2018, with 25% vesting on the first anniversary of the vesting commencement date and 1/48th vesting each month thereafter over the remaining three years, subject to Ms. McDowell's Continuous Service (as defined in the Plan) through each such vesting date."}],"balance_after":110000,"derivative":{"exercise_price":28.3,"expiration_date":"2028-04-30","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001479290-18-000062","document":"wf-form4_152539340405676.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000147929018000062/wf-form4_152539340405676.xml","form_type":"4"}},{"id":3947630,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Common Stock","published_at":"2018-05-03T20:23:37.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares subject to the Restricted Stock award shall vest in four (4) equal annual installments beginning from June 15, 2018, subject to Ms. McDowell's Continuous Service (as defined in the Issuer's 2014 Inducement Plan (the \"Plan\")) on each vesting date."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001479290-18-000062","document":"wf-form4_152539340405676.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674232/000147929018000062/wf-form4_152539340405676.xml","form_type":"4"}},{"id":4024817,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-02T00:12:17.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":14774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"When the ISO and NQ dated 02/27/2018 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/27/2022."}],"balance_after":14774,"derivative":{"exercise_price":7.8,"expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":14774},"source":{"system":"sec-edgar","filing":"0001061983-18-000017","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000017/edgardoc.xml","form_type":"4"}},{"id":4024816,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-03-02T00:12:17.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":15226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"When the ISO and NQ dated 02/27/2018 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/27/2022."}],"balance_after":15226,"derivative":{"exercise_price":7.8,"expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":15226},"source":{"system":"sec-edgar","filing":"0001061983-18-000017","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000017/edgardoc.xml","form_type":"4"}},{"id":4024815,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-03-02T00:12:17.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":2452,"price":7.75,"value":19003.0,"ownership":{"direct":true},"balance_after":32548,"source":{"system":"sec-edgar","filing":"0001061983-18-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000017/edgardoc.xml","form_type":"4"}},{"id":4024814,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-03-02T00:12:17.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":20000,"price":0.001,"value":20.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The restricted stock units vest in three annual installments.  Vested shares will be delivered to the reporting person as follows: 40% on 02/27/2019, 40% on 02/27/2020 and 20% on 03/01/2021."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001061983-18-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000017/edgardoc.xml","form_type":"4"}},{"id":4096807,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":77,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":921,"derivative":{"exercise_price":6.67,"exercise_date":"2016-03-23","expiration_date":"2026-02-23","underlying":"Common Stock","underlying_shares":77},"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096806,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":77,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":998,"derivative":{"exercise_price":6.67,"exercise_date":"2016-03-23","expiration_date":"2026-02-23","underlying":"Common Stock","underlying_shares":77},"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096805,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":653,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18038,"derivative":{"exercise_price":6.67,"exercise_date":"2016-03-23","expiration_date":"2026-02-23","underlying":"Common Stock","underlying_shares":653},"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096804,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":652,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18691,"derivative":{"exercise_price":6.67,"exercise_date":"2016-03-23","expiration_date":"2026-02-23","underlying":"Common Stock","underlying_shares":652},"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096803,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10625,"derivative":{"exercise_price":6.37,"exercise_date":"2016-05-29","expiration_date":"2025-05-29","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096802,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11250,"derivative":{"exercise_price":6.37,"exercise_date":"2016-05-29","expiration_date":"2025-05-29","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096801,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":625,"price":9,"value":5625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096800,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":625,"price":6.37,"value":3981.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15625,"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096799,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":625,"price":9,"value":5625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096798,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":625,"price":6.37,"value":3981.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15625,"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096797,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":653,"price":9,"value":5877.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096796,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":653,"price":6.67,"value":4355.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15653,"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096795,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":652,"price":9,"value":5868.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096794,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":652,"price":6.67,"value":4348.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15652,"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096793,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":77,"price":9,"value":693.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096792,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":77,"price":6.67,"value":513.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15077,"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096791,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":77,"price":9,"value":693.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4096790,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2018-01-19T01:10:41.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":77,"price":6.67,"value":513.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15077,"source":{"system":"sec-edgar","filing":"0001061983-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000007/edgardoc.xml","form_type":"4"}},{"id":4171681,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-11-07T01:19:01.000Z","date":"2017-11-02","kind":"exercise","acquired":false,"shares":77,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1075,"derivative":{"exercise_price":6.67,"exercise_date":"2016-03-23","expiration_date":"2026-02-23","underlying":"Common Stock","underlying_shares":77},"source":{"system":"sec-edgar","filing":"0001061983-17-000065","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000065/edgardoc.xml","form_type":"4"}},{"id":4171680,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-11-07T01:19:01.000Z","date":"2017-11-02","kind":"exercise","acquired":false,"shares":653,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19343,"derivative":{"exercise_price":6.67,"exercise_date":"2016-03-23","expiration_date":"2026-02-23","underlying":"Common Stock","underlying_shares":653},"source":{"system":"sec-edgar","filing":"0001061983-17-000065","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000065/edgardoc.xml","form_type":"4"}},{"id":4171679,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-11-07T01:19:01.000Z","date":"2017-11-02","kind":"exercise","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11875,"derivative":{"exercise_price":6.37,"exercise_date":"2016-05-29","expiration_date":"2025-05-29","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0001061983-17-000065","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000065/edgardoc.xml","form_type":"4"}},{"id":4171678,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-11-07T01:19:01.000Z","date":"2017-11-02","kind":"exercise","acquired":true,"shares":625,"price":6.37,"value":3981.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001061983-17-000065","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000065/edgardoc.xml","form_type":"4"}},{"id":4171677,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-11-07T01:19:01.000Z","date":"2017-11-02","kind":"sale","acquired":false,"shares":1800,"price":13,"value":23400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":14375,"source":{"system":"sec-edgar","filing":"0001061983-17-000065","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000065/edgardoc.xml","form_type":"4"}},{"id":4171676,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-11-07T01:19:01.000Z","date":"2017-11-02","kind":"exercise","acquired":true,"shares":653,"price":6.67,"value":4355.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":16175,"source":{"system":"sec-edgar","filing":"0001061983-17-000065","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000065/edgardoc.xml","form_type":"4"}},{"id":4171675,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-11-07T01:19:01.000Z","date":"2017-11-02","kind":"sale","acquired":false,"shares":2460,"price":12.9,"value":31734.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":15522,"source":{"system":"sec-edgar","filing":"0001061983-17-000065","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000065/edgardoc.xml","form_type":"4"}},{"id":4171674,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-11-07T01:19:01.000Z","date":"2017-11-02","kind":"exercise","acquired":true,"shares":77,"price":6.67,"value":513.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":17982,"source":{"system":"sec-edgar","filing":"0001061983-17-000065","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000065/edgardoc.xml","form_type":"4"}},{"id":4189349,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"exercise","acquired":false,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1152,"derivative":{"exercise_price":6.67,"exercise_date":"2016-03-23","expiration_date":"2026-02-23","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189348,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"exercise","acquired":false,"shares":3719,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19996,"derivative":{"exercise_price":6.67,"exercise_date":"2016-03-23","expiration_date":"2026-02-23","underlying":"Common Stock","underlying_shares":3719},"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189347,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"exercise","acquired":false,"shares":6357,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12500,"derivative":{"exercise_price":6.37,"exercise_date":"2016-05-29","expiration_date":"2025-05-29","underlying":"Common Stock","underlying_shares":6357},"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189346,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":1598,"price":15.7,"value":25088.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":16771,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189345,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":200,"price":15.95,"value":3190.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":18369,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189344,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":200,"price":15.75,"value":3150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":18569,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189343,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":100,"price":15.725,"value":1572.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":18769,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189342,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":1100,"price":15.7,"value":17270.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":18869,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189341,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":800,"price":15.675,"value":12540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":19969,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189340,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":700,"price":15.65,"value":10955.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":20769,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189339,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":200,"price":15.625,"value":3125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":21469,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189338,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":1100,"price":15.6,"value":17160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":21669,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189337,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":400,"price":15.575,"value":6230.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":22769,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189336,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":700,"price":15.55,"value":10885.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":23169,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189335,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":200,"price":15.5,"value":3100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":23869,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189334,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":600,"price":15.4,"value":9240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":24069,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189333,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":1106,"price":15.35,"value":16977.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":24669,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189332,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":200,"price":15.325,"value":3065.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":25775,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189331,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":1094,"price":15.3,"value":16738.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":25975,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189330,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":383,"price":15.275,"value":5850.325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":27069,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189329,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"exercise","acquired":true,"shares":3719,"price":6.67,"value":24805.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":27452,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189328,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":500,"price":15.25,"value":7625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":23733,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189327,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"exercise","acquired":true,"shares":1507,"price":6.67,"value":10051.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":24233,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189326,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":2000,"price":15.2,"value":30400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":22726,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4189325,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:20:08.000Z","date":"2017-10-06","kind":"exercise","acquired":true,"shares":6357,"price":6.37,"value":40494.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":24726,"source":{"system":"sec-edgar","filing":"0001061983-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000060/edgardoc.xml","form_type":"4"}},{"id":4213854,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-09-08T20:48:13.000Z","date":"2017-09-06","kind":"exercise","acquired":false,"shares":1432,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2659,"derivative":{"exercise_price":6.67,"exercise_date":"2016-03-23","expiration_date":"2026-02-23","underlying":"Common Stock","underlying_shares":1432},"source":{"system":"sec-edgar","filing":"0001061983-17-000057","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000057/edgardoc.xml","form_type":"4"}},{"id":4213853,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-09-08T20:48:13.000Z","date":"2017-09-06","kind":"exercise","acquired":false,"shares":3067,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23715,"derivative":{"exercise_price":6.67,"exercise_date":"2016-03-23","expiration_date":"2026-02-23","underlying":"Common Stock","underlying_shares":3067},"source":{"system":"sec-edgar","filing":"0001061983-17-000057","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000057/edgardoc.xml","form_type":"4"}},{"id":4213852,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-09-08T20:48:13.000Z","date":"2017-09-06","kind":"exercise","acquired":false,"shares":5732,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18857,"derivative":{"exercise_price":6.37,"exercise_date":"2016-05-29","expiration_date":"2025-05-29","underlying":"Common Stock","underlying_shares":5732},"source":{"system":"sec-edgar","filing":"0001061983-17-000057","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000057/edgardoc.xml","form_type":"4"}},{"id":4213851,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:13.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":100,"price":15,"value":1500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":18369,"source":{"system":"sec-edgar","filing":"0001061983-17-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000057/edgardoc.xml","form_type":"4"}},{"id":4213850,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":707,"price":14.95,"value":10569.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":18469,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213849,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":400,"price":14.925,"value":5970.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":19176,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213848,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":600,"price":14.9,"value":8940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":19576,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213847,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":724,"price":14.85,"value":10751.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":20176,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213846,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":100,"price":14.825,"value":1482.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":20900,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213845,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":400,"price":14.8,"value":5920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":21000,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213844,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":400,"price":14.775,"value":5910.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":21400,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213843,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":600,"price":14.75,"value":8850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":21800,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213842,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":200,"price":14.725,"value":2945.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":22400,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213841,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":500,"price":14.7,"value":7350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":22600,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213840,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":200,"price":14.65,"value":2930.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":23100,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213839,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":300,"price":14.625,"value":4387.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":23300,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213838,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":700,"price":14.6,"value":10220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":23600,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213837,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":200,"price":14.575,"value":2915.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":24300,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213836,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":200,"price":14.525,"value":2905.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":24500,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213835,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":200,"price":14.5,"value":2900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":24700,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213834,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":200,"price":14.475,"value":2895.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":24900,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213833,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":600,"price":14.45,"value":8670.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":25100,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213832,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":400,"price":14.4,"value":5760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":25700,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213831,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":200,"price":14.375,"value":2875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":26100,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213830,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":200,"price":14.35,"value":2870.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":26300,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213829,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":302,"price":14.3,"value":4318.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":26500,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213828,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":100,"price":14.275,"value":1427.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":26802,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213827,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":400,"price":14.25,"value":5700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":26902,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}},{"id":4213826,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":126407,"kind":"person","name":"McDowell Caryn Gordon","position":1,"cik":"0001674232","reported_name":"McDowell Caryn Gordon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-09-08T20:48:02.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":898,"price":14.2,"value":12751.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017."}],"balance_after":27302,"source":{"system":"sec-edgar","filing":"0001061983-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000056/edgardoc.xml","form_type":"4"}}],"next_cursor":"2017-09-08T20:48:02.000000Z,4213826"}